FDA inspection
Eurofins BioPharma Product Testing Toronto, Inc.: FDA inspection ending Nov 15, 2019
FDA inspection 1110749 · Voluntary Action Indicated (VAI) · North York
Key facts
| Inspection ID | 1110749 |
|---|---|
| Firm | Eurofins BioPharma Product Testing Toronto, Inc. |
| FEI number | 3002996761 |
| Address | 1111 Flint Rd Unit 36 |
| City | North York |
| Country | Canada |
| Fiscal year | 2020 |
| Inspection end date | Nov 15, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data